Runway Growth Finance Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw lower investment income and NAV, but the SWK acquisition diversified the portfolio and is expected to be accretive to EPS by Q3. Non-accruals impacted risk ratings and earnings, but liquidity remains strong and a $15M share repurchase program was launched.
Fiscal Year 2025
-
Q4 2025 saw lower investment income and net income sequentially, but portfolio activity remained robust with 7 new investments and a strong pipeline for 2026. The pending SWK Holdings acquisition is set to diversify assets and enhance healthcare exposure, while capital optimization and disciplined risk management continue.
-
Q3 2025 saw higher investment income and net investment income, with strong origination activity and a focus on portfolio diversification. The announced SWK Holdings acquisition is expected to scale assets, boost healthcare exposure, and be accretive post-close.
-
A definitive merger agreement has been reached to acquire a specialty finance company focused on healthcare and life sciences, increasing portfolio diversification and scale. The $220 million NAV-for-NAV, tax-free merger is expected to close by early 2026, pending approvals.
-
Q2 2025 saw investment income of $35.1M and net investment income of $13.9M, with a focus on portfolio optimization, diversification, and new product offerings. NAV per share rose to $13.66, and liquidity remains strong. Management expects a brighter outlook for 2026, prioritizing quality and diversification.
-
Q1 2025 saw $35.4M in investment income and $15.6M net investment income, with portfolio value and NAV per share declining slightly. Management remains focused on disciplined underwriting, liquidity, and selective growth, while launching a $25M stock repurchase and maintaining a stable dividend.
Fiscal Year 2024
-
Q4 2024 saw strong portfolio performance with $33.8M in investment income and improved credit quality. The advisor's acquisition by BC Partners Credit enhances origination and diversification, while a new dividend policy aims for stability. NAV per share rose 3% sequentially.
-
Q3 2024 saw $75.3M in new investments, stable credit quality, and a portfolio fair value of $1.07B. The advisor's acquisition by BC Partners is expected to accelerate originations and diversify offerings, while the board paused supplemental dividends to focus on NAV growth.
-
Q2 2024 saw $75.5M in new investments, $34.2M in investment income, and a NAV per share of $13.14. Prepayments are expected to total $200–$300M in H2, supporting dividend coverage and portfolio redeployment. The portfolio remains high quality, with a disciplined credit approach.